← Evidence map

ArticleBMC cancer2026

New biomarker in the early diagnosis of breast cancer: adiponectin, asprosin, adropin, and resistin.

Ömer Çelik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42174492